@mylu wrote:
About Metropolis
Metropolis Labs is a chain of diagnostic companies, with its central laboratory in Mumbai, Maharashtra. Metropolis Healthcare has a chain of 106 clinical laboratories and 1130 collection centers across 7 countries including India. The healthcare company was founded in 1980, as a single laboratory with a revenue of about US$1.5 million and 4500 employees.
The company offers a broad range of clinical laboratory tests (3,487)
and 530 profiles. It follows a ‘hub & spoke’ model for quick and efficient delivery of services through laboratory and service network, which covers 197 cities in India. As of 9MFY19, its laboratory network consists of 115 clinical laboratories, comprising a global reference laboratory, 14 regional reference laboratories, 56 satellite laboratories, 44 express laboratories.The company caters to both individual (1631 touch points) and institutional
customers (9552 touch points). Metropolis has also been awarded tender from National Aids Control Organisation (Naco). Outside India, the company
has laboratory operations in Ghana, Kenya, Zambia, Mauritius and Sri Lanka. Also, it has entered into agreements with third parties for collection and processing of specimens in Nepal, Nigeria, UAE and Oman.IPO:
Metropolis Healthcare came up with IPO in April month with a price band of Rs 877-880 per share. The issue comprised of 1,36,85,095 equity shares included offer for sale of up to 62,72,335 equity shares by promoter Dr Sushil Kanubhai Shah and up to 74,12,760 shares by CA Lotus Investments (investor selling shareholder).Financials
Standalone Balance Sheet
Standalone Income Statement
Competitors:
Dr Lal path Labs , SRL Diagnostic , Thyrocare Technologies.Observation (may be red flag also):
The company is seen doing lot of acquisitions and lot of subsidiary/ holding companies (according to their annual report around 19 of them including overseas) .My View:
I strongly feel that diagnostic healthcare will be a closely watched sector in the coming years as people has become increasingly conscious about their health.
Though , lot of unorganized centers in each and every location is a biggest challenge , it will be interesting to see how branded companies succeed in this race.
This post is not a recommendation and individual investors are requested to do their analysis before investing.
Acknowledgements:
http://content.icicidirect.com/mailimages/IDirect_Metropolis_IPOReview.pdf
Posts: 1
Participants: 1